Gregory W. Gin

Corporate Officer/Principal at EVC Group, Inc.

Health Technology

Profile

Gregory W.
Gin is currently a Principal at EVC Group, Inc. He previously worked as Director-Investor Relations at Genta, Inc., Investor Relations Contact at Edge Therapeutics, Inc., and Investor & Media Contact at Affimed NV.

Gregory W. Gin active positions

Companies	Position	Start
EVC Group, Inc.	Corporate Officer/Principal	-

All active positions of Gregory W. Gin

Former positions of Gregory W. Gin

Companies	Position	End
Edge Therapeutics, Inc. Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.	Investor Relations Contact	-
AFFIMED N.V.	Investor Relations Contact	-
Genta, Inc. Genta, Inc. Pharmaceuticals: MajorHealth Technology Genta, Inc. is in the process of bankruptcy. The company formerly engages in pharmaceutical research and development. Genta was founded on February 4, 1988 and is headquartered in Berkeley Heights, NJ.	Public Communications Contact	-

See the detail of Gregory W. Gin's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gregory W. Gin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
AFFIMED N.V.	Health Technology

Private companies	3
Genta, Inc. Genta, Inc. Pharmaceuticals: MajorHealth Technology Genta, Inc. is in the process of bankruptcy. The company formerly engages in pharmaceutical research and development. Genta was founded on February 4, 1988 and is headquartered in Berkeley Heights, NJ.	Health Technology
Edge Therapeutics, Inc. Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.	Health Technology
EVC Group, Inc.

See company connections

Stock Market
Insiders
Gregory W. Gin